171 related articles for article (PubMed ID: 30393581)
1. Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.
Mesiano G; Grignani G; Fiorino E; Leuci V; Rotolo R; D'Ambrosio L; Salfi C; Gammaitoni L; Giraudo L; Pisacane A; Butera S; Pignochino Y; Basiricó M; Capozzi F; Sapino A; Aglietta M; Sangiolo D
Oncoimmunology; 2018; 7(11):e1465161. PubMed ID: 30393581
[TBL] [Abstract][Full Text] [Related]
2. Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.
Gammaitoni L; Giraudo L; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
Clin Cancer Res; 2017 May; 23(9):2277-2288. PubMed ID: 27815354
[No Abstract] [Full Text] [Related]
3. Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'Aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G
Cancer Res; 2014 Jan; 74(1):119-29. PubMed ID: 24356422
[TBL] [Abstract][Full Text] [Related]
4. Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features.
Gammaitoni L; Giraudo L; Leuci V; Todorovic M; Mesiano G; Picciotto F; Pisacane A; Zaccagna A; Volpe MG; Gallo S; Caravelli D; Giacone E; Venesio T; Balsamo A; Pignochino Y; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
Clin Cancer Res; 2013 Aug; 19(16):4347-58. PubMed ID: 23794732
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition.
Wei F; Rong XX; Xie RY; Jia LT; Wang HY; Qin YJ; Chen L; Shen HF; Lin XL; Yang J; Yang S; Hao WC; Chen Y; Xiao SJ; Zhou HR; Lin TY; Chen YS; Sun Y; Yao KT; Xiao D
Oncotarget; 2015 Oct; 6(33):35023-39. PubMed ID: 26418951
[TBL] [Abstract][Full Text] [Related]
6. Activity of cytokine-induced killer cells against bone and soft tissue sarcoma.
Sangiolo D; Mesiano G; Gammaitoni L; Aglietta M; Grignani G
Oncoimmunology; 2014; 3():e28269. PubMed ID: 25050197
[TBL] [Abstract][Full Text] [Related]
7. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.
Leuci V; Casucci GM; Grignani G; Rotolo R; Rossotti U; Vigna E; Gammaitoni L; Mesiano G; Fiorino E; Donini C; Pisacane A; Ambrosio LD; Pignochino Y; Aglietta M; Bondanza A; Sangiolo D
Oncoimmunology; 2018; 7(5):e1423167. PubMed ID: 29721373
[TBL] [Abstract][Full Text] [Related]
8. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
9. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
[TBL] [Abstract][Full Text] [Related]
10. Generation of CD3+ CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells.
Hongeng S; Petvises S; Worapongpaiboon S; Rerkamnuaychoke B; Pakakasama S; Jootar S
Int J Hematol; 2003 Feb; 77(2):175-9. PubMed ID: 12627854
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
Lin T; Song C; Chuo DY; Zhang H; Zhao J
Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.
Merker M; Pfirrmann V; Oelsner S; Fulda S; Klingebiel T; Wels WS; Bader P; Rettinger E
Oncotarget; 2017 Sep; 8(39):66137-66153. PubMed ID: 29029499
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.
Liu J; Wang L; Wang Y; Zhang W; Cao Y
PLoS One; 2017; 12(4):e0175704. PubMed ID: 28426690
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
15. MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.
Chen Y; Lin J; Guo ZQ; Lin WS; Zhou ZF; Huang CZ; Chen Q; Ye YB
Am J Cancer Res; 2015; 5(10):3221-30. PubMed ID: 26693072
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic selection or irradiation eliminates alloreactive cells but also reduces anti-tumor potential of cytokine-induced killer cells: implications for unmanipulated cytokine-induced killer cell infusion.
Rettinger E; Kreyenberg H; Merker M; Kuçi S; Willasch A; Bug G; Ullrich E; Wels WS; Bonig H; Klingebiel T; Bader P
Cytotherapy; 2014 Jun; 16(6):835-44. PubMed ID: 24582456
[TBL] [Abstract][Full Text] [Related]
17. Adoptive immunotherapy against sarcomas.
Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D
Expert Opin Biol Ther; 2015 Apr; 15(4):517-28. PubMed ID: 25516119
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.
Chen Y; Guo ZQ; Shi CM; Zhou ZF; Ye YB; Chen Q
Int J Clin Exp Med; 2015; 8(5):7728-36. PubMed ID: 26221323
[TBL] [Abstract][Full Text] [Related]
19. Recognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognition.
Rong XX; Wei F; Lin XL; Qin YJ; Chen L; Wang HY; Shen HF; Jia LT; Xie RY; Lin TY; Hao WC; Yang J; Yang S; Cheng YS; Huang WH; Li AM; Sun Y; Luo RC; Xiao D
Oncoimmunology; 2016 Mar; 5(3):e1086060. PubMed ID: 27141341
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia.
Yang XY; Zeng H; Chen FP
Oncol Lett; 2015 Feb; 9(2):535-541. PubMed ID: 25621022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
